Covid-19 Vaccine Acceptance and Determinant Factors among General Public in East Africa: A Systematic Review and Meta-Analysis
- PMID: 35720257
- PMCID: PMC9201368
- DOI: 10.1177/23333928221106269
Covid-19 Vaccine Acceptance and Determinant Factors among General Public in East Africa: A Systematic Review and Meta-Analysis
Abstract
Background: Vaccines are an effective and ideal solution that can reduce the burden of disease worldwide. Although vaccines are the most effective way to prevent infectious diseases. Anti-vaccine conspiracy theories impair vaccination acceptance intentions. Several studies were conducted in East Africa. However, these studies had reported inconsistent findings. Therefore, this systematic review aimed to pool the prevalence of COVID-19 vaccine acceptance and identify its determinants.
Methods: PubMed, Google Scholar, and GLOBAL HEALTH databases were used to retrieve previously published studies. All papers published in the English language up to February 28, 2022 were included. The result was written and reported according to the PRISMA updated guideline. A random-effect model was used to estimate the pooled prevalence and effect sizes. Heterogeneity was assessed using I2 test statistics. Publication bias was assessed using funnel plot and egger's test statistics. Statistical tests result at P-value<0.05 were declared as having significance.Result: A total of 25 Cross-sectional studies with a total sample size of 33,044 were included in this study. The pooled prevalence of Covid-19 vaccine acceptance was 60.2%, (95%CI: 52.8- 67.3). Egger's test statistics (P = 0.003) showed there is a significant publication bias. Attending above secondary school (AOR: 2.1, 95%CI: 1.37, 2.96), having good knowledge about the vaccine (AOR: 2.1, 95%CI: 1.6, 2.8), having a positive attitude towards vaccine (AOR: 3.8, 95%CI: 2.3, 6.2), history of COVID-19 infection (AOR: 2.7, 95%CI: 1.6, 4.7) and being male (AOR: 1.8, 95%CI: 1.2, 2.7) were found to have a significant association with COVID-19 vaccine acceptance.
Conclusion: The COVID-19 vaccination acceptance rate was good, but it could be improved. The findings could help governments to figure out the best way to carry out COVID-19 mass vaccination campaigns. There is a lack of data in most countries. Therefore, we suggest more studies be conducted in the future.
Keywords: COVID-19 vaccine; vaccine acceptance; vaccine acceptance determinants.
© The Author(s) 2022.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures







Similar articles
-
Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis.PLoS One. 2022 Jun 3;17(6):e0269273. doi: 10.1371/journal.pone.0269273. eCollection 2022. PLoS One. 2022. PMID: 35657814 Free PMC article.
-
COVID-19 vaccine acceptance and its associated factors in Ethiopia: A systematic review and meta-analysis.Clin Epidemiol Glob Health. 2022 Mar-Apr;14:101001. doi: 10.1016/j.cegh.2022.101001. Epub 2022 Mar 7. Clin Epidemiol Glob Health. 2022. PMID: 35284688 Free PMC article. Review.
-
Global COVID-19 vaccine acceptance level and its determinants: an umbrella review.BMC Public Health. 2024 Jan 2;24(1):5. doi: 10.1186/s12889-023-17497-4. BMC Public Health. 2024. PMID: 38166750 Free PMC article.
-
The Acceptance Rate Toward COVID-19 Vaccine in Africa: A Systematic Review and Meta-analysis.Glob Pediatr Health. 2021 Sep 30;8:2333794X211048738. doi: 10.1177/2333794X211048738. eCollection 2021. Glob Pediatr Health. 2021. PMID: 34616860 Free PMC article. Review.
-
A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs).PLoS One. 2022 Dec 1;17(12):e0278224. doi: 10.1371/journal.pone.0278224. eCollection 2022. PLoS One. 2022. PMID: 36455209 Free PMC article.
Cited by
-
Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol.Pharmaceutics. 2022 Oct 22;14(11):2259. doi: 10.3390/pharmaceutics14112259. Pharmaceutics. 2022. PMID: 36365078 Free PMC article.
-
Declining trends in vaccine confidence across sub-Saharan Africa: A large-scale cross-sectional modeling study.Hum Vaccin Immunother. 2023 Dec 31;19(1):2213117. doi: 10.1080/21645515.2023.2213117. Epub 2023 Jun 8. Hum Vaccin Immunother. 2023. PMID: 37290478 Free PMC article.
-
COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis.JMIR Public Health Surveill. 2024 Apr 30;10:e54769. doi: 10.2196/54769. JMIR Public Health Surveill. 2024. PMID: 38687992 Free PMC article.
-
COVID-19 vaccine acceptance and its association with knowledge and attitude among patients with chronic diseases in Ethiopia.Hum Vaccin Immunother. 2024 Dec 31;20(1):2350815. doi: 10.1080/21645515.2024.2350815. Epub 2024 May 17. Hum Vaccin Immunother. 2024. PMID: 38757639 Free PMC article.
-
Determinants of vaccine acceptance, knowledge, attitude, and prevention practices against COVID-19 among governmental healthcare workers in Addis Ababa and Adama, Ethiopia: A cross-sectional study.Health Sci Rep. 2023 Jan 18;6(1):e1074. doi: 10.1002/hsr2.1074. eCollection 2023 Jan. Health Sci Rep. 2023. PMID: 36698705 Free PMC article.
References
-
- WHO. WHO Director-General's opening remarks at the media briefing on COVID-19–11 March 2020. Updated 11 March 2020. Accessed Feburary 1, 2022. https://www.who.int/director-general/speeches/detail/who-director-genera....
-
- PAHO. WHO declares Public Health Emergency on novel coronavirus. Updated 30 Jan 2020. Accessed Feburary 1, 2022. https://www.paho.org/en/news/30-1-2020-who-declares-public-health-emerge....
-
- WHO. WHO Coronavirus (COVID-19) Dashboard Accessed January 10, 2022. https://covid19.who.int/.
-
- WHO. WHO Coronavirus (COVID-19) Dashboard. Accessed January 10, 2022. https://covid19.who.int/region/afro/country/et.
-
- Baye K. COVID-19 prevention measures in Ethiopia: Current realities and prospects. International Food Policy Research Institute (IFPRI). 2020;(ESSP Working Paper 141).
Publication types
LinkOut - more resources
Full Text Sources